Insider Trading & Ownership - Mazar Andrew Paul

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mazar Andrew Paul
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-02-11
Sale
2021-02-16
7:35 pm
Monopar TherapeuticsMNPRTactic Pharma LLC
Mazar Andrew Paul
Robinson Chandler
O'Halloran Thomas V.
Brown Michael J
10% Owner
125,000$14.64$1,830,6204,277,940
(Indirect
Direct)
View
2019-12-18
Purchase
2019-12-20
6:33 pm
Monopar TherapeuticsMNPRTactic Pharma LLC
Mazar Andrew Paul
Robinson Chandler
O'Halloran Thomas V.
Brown Michael J
10% Owner
125,000$8$1,000,0004,402,940
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-08-12
9:47 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUMazar Andrew Paul
Chief Operating Officer
0$0164,624
(Direct)
View
2022-03-31
Tax Withholding
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
471$2.554,388,857
(Direct)
View
2022-03-31
Exercise
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
1,606$04,388,857
(Direct)
View
2022-02-02
Option Award
2022-02-04
7:38 pm
N/A
2032-02-01
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
156,125$0179,272
(Direct)
View
2022-01-01
Tax Withholding
2022-01-04
2:49 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
671$3.214,302,804
(Direct)
View
2022-01-01
Exercise
2022-01-04
2:49 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
1,937$04,302,804
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
2:40 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
556$3.214,316,937
(Direct)
View
2021-12-31
Exercise
2022-01-04
2:40 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
1,606$04,316,937
(Direct)
View
2021-09-30
Tax Withholding
2021-10-01
7:31 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
471$4.874,317,493
(Direct)
View
2021-09-30
Exercise
2021-10-01
7:31 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
1,606$04,317,493
(Direct)
View
2021-06-30
Exercise
2021-07-02
5:11 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
3,212$04,317,964
(Direct)
View
2021-06-30
Tax Withholding
2021-07-02
5:11 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
942$5.894,317,964
(Direct)
View
2021-01-26
Option Award
2021-01-28
6:49 pm
N/A
2031-01-25
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
61,774$067,585
(Direct)
View
2021-01-01
Exercise
2021-01-05
5:38 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
1,937$04,424,020
(Direct)
View
2021-01-01
Tax Withholding
2021-01-05
5:38 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
671$6.124,424,020
(Direct)
View
2020-01-31
Option Award
2020-02-20
8:55 pm
N/A
N/A
Monopar TherapeuticsMNPRMazar Andrew Paul
Chief Scientific Officer
39,941$039,941
(Direct)
View